
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TADA2B Double Nickase Plasmid (h) | sc-406224-NIC | 20 µg | $410.00 | |||
TADA2B Double Nickase Plasmid (h2) | sc-406224-NIC-2 | 20 µg | $410.00 |
TADA2B encodes a transcriptional adaptor component of the SAGA/ATAC histone acetyltransferase coactivator complexes, linking sequence-specific transcription factors to chromatin-modifying machinery. Through interactions with GCN5/PCAF and related subunits, TADA2B contributes to histone acetylation, promoter accessibility, and coordinated regulation of gene expression programs involved in cell cycle control, differentiation, and responses to cellular stress. Perturbation of SAGA/ATAC complex integrity can disrupt epigenetic regulation and transcriptional homeostasis, processes frequently implicated in oncogenic transformation and other disorders of gene regulation. As a chromatin-associated regulator, TADA2B is relevant for studying mechanisms that couple histone acetylation to transcription initiation and enhancer–promoter communication in human cells.
TADA2B Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the TADA2B locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within TADA2B. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt TADA2B function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of TADA2B-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.